Skip to main content
Premium Trial:

Request an Annual Quote

Number Crunch: Sep 1, 2001


Number Crunch

Why Pharmas Fear Failure

$880 million

Estimated cost to develop a novel drug

$660 million

Cost attributed to failures of other drugs tested

$200 million

Average amount that could be saved by eliminating one in 10 drug targets from research

$300 million

Savings estimated per novel drug if pharmas can properly implement genomics technologies along the way

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.